CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Detection of anti-COVID-19 antibody levelWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (8)


Name (Synonyms) Correlation
D003139 Common Cold NIH 0.71
D029424 Pulmonary Disease, Chronic Obstructive NIH 0.58
D008173 Lung Diseases, Obstructive NIH 0.45
D012141 Respiratory Tract Infections NIH 0.23
D003141 Communicable Diseases NIH 0.11
D007239 Infection NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (3)


Name (Synonyms) Correlation
HP:0006510 Chronic obstructive pulmonary disease HPO 0.58
HP:0006536 Obstructive lung disease HPO 0.45
HP:0011947 Respiratory tract infection HPO 0.23

There is one clinical trial.

Clinical Trials


1 Observational Cohort Study for the Detection of Anti-COVID-19 Antibody Levels in an Hospital Population

COVID-19 (SARS-CoV-2) infection in health professionals represent a significant criticality both for the risk of spreading the disease and for the organizational aspects that follow. The objective of the study is to evaluate the spread of COVID-19 virus within the hospital population of Humanitas through the monitoring of the levels of IgG antibodies. Moreover, viral load will be measured by RT-PCR in the subgroup positive to IgG antibodies.

NCT04387929 COVID-19 Diagnostic Test: Detection of anti-COVID-19 antibody level

Primary Outcomes

Description: Measurement of the temporal trend of the antibody value of anti-SARS-CoV-2 neutralizing IgG.

Measure: SARS-CoV-2 levels of IgG antibodies

Time: 1 year

Secondary Outcomes

Description: Measurement of the viral load of the nasopharyngeal swab in antibody test positive subjects and the correlation between the antibody titer and virus positivity or negativity.

Measure: SARS-CoV-2 viral load in nasopharyngeal swab of IgG positive subjects

Time: 1 year

Description: The association between the antibody value and potential protective or risk factors of the subject participating in the study such as age, clinical history, vaccination history, workplace, professional category, etc.

Measure: Epidemiology correlations

Time: 1 year


No related HPO nodes (Using clinical trials)